A single dose of an experimental Ebola virus vaccine that was being tested on humans, completely protects cynomolgus macaques (Monkeys) too against the current EBOV outbreak strain, if it is given at least seven days before exposure.If the vaccine is given them 3 days earlier then it partially protects Monkeys.
The live-attenuated vaccine, VSV-EBOV, uses genetically engineered vesicular stomatitis virus to carry an EBOV gene that has safely induced protective immunity in macaques.
About VSV-EBOV
- It is an experimental vaccine for protecting againstEbola virus disease.
- It was developed by scientists at the National Microbiology Laboratory.
- The Public Health Agency of Canada (PHAC) developed the vaccine, and took out associated patent in 2003
General Related Quesion:
- What is the full form of VSV-EBOV?
